Comment on "48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse".
作者信息
Guo Yafei, Wang Lingan
机构信息
Department of Hematology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China.
Department of Pediatrics, Guangdong Women and Children's Hospital, Guangzhou 511442, China.
出版信息
Can J Gastroenterol Hepatol. 2019 Jan 1;2019:4927083. doi: 10.1155/2019/4927083. eCollection 2019.
Abstract
摘要
相似文献
1
Comment on "48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse".关于“慢性乙型肝炎患者核苷（酸）类似物治疗停药后48周结局及复发相关因素”的评论
Can J Gastroenterol Hepatol. 2019 Jan 1;2019:4927083. doi: 10.1155/2019/4927083. eCollection 2019.
2
Response to: Comment on "48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse".对《慢性乙型肝炎患者核苷（酸）类似物治疗停药后48周结局及复发相关因素》评论的回应
Can J Gastroenterol Hepatol. 2019 May 2;2019:2970510. doi: 10.1155/2019/2970510. eCollection 2019.
3
Hepatitis B virus-specific T cell responses after stopping nucleos(t)ide analogue therapy in HBeAg-negative chronic hepatitis B.停止 HBeAg 阴性慢性乙型肝炎核苷（酸）类似物治疗后乙型肝炎病毒特异性 T 细胞应答。
J Hepatol. 2018 Sep;69(3):584-593. doi: 10.1016/j.jhep.2018.05.004. Epub 2018 Jun 29.
4
Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B.系统评价：乙型肝炎e抗原阴性慢性乙型肝炎患者长期核苷（酸）类似物治疗的停药情况
Aliment Pharmacol Ther. 2015 Aug;42(3):243-57. doi: 10.1111/apt.13272. Epub 2015 Jun 10.
5
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.聚乙二醇干扰素 α-2a 联合核苷（酸）类似物治疗与单独核苷（酸）类似物治疗对 HBeAg 阴性慢性乙型肝炎患者持续不可检测的血浆乙型肝炎病毒 DNA 的影响：一项随机、对照、开放标签试验。
Lancet Gastroenterol Hepatol. 2017 Mar;2(3):177-188. doi: 10.1016/S2468-1253(16)30189-3. Epub 2017 Jan 20.
6
Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy.血清乙型肝炎核心蛋白抗体水平与核苷（酸）类似物治疗停药后临床复发相关。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):182-191.e1. doi: 10.1016/j.cgh.2018.05.047. Epub 2018 Jun 11.
7
Reduced risk of relapse after long-term nucleos(t)ide analogue consolidation therapy for chronic hepatitis B.长期核苷（酸）类似物巩固治疗慢性乙型肝炎后复发风险降低。
Aliment Pharmacol Ther. 2015 May;41(9):867-76. doi: 10.1111/apt.13150. Epub 2015 Mar 5.
8
Nucleos(t)ide analogues only induce temporary hepatitis B e antigen seroconversion in most patients with chronic hepatitis B.核苷（酸）类似物仅能使大多数慢性乙型肝炎患者的乙型肝炎 e 抗原血清学转换暂时发生。
Gastroenterology. 2010 Aug;139(2):491-8. doi: 10.1053/j.gastro.2010.03.059. Epub 2010 Apr 8.
9
Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues.核苷（酸）类似物长期有效治疗后乙型肝炎病毒特异性 T 细胞功能的恢复。
Gastroenterology. 2012 Oct;143(4):963-73.e9. doi: 10.1053/j.gastro.2012.07.014. Epub 2012 Jul 14.
10
The Role of Hepatitis B Surface Antigen in Nucleos(t)ide Analogue Cessation Among Asian Chronic Hepatitis B Patients: Friend or Foe?乙肝表面抗原在亚洲慢性乙型肝炎患者核苷（酸）类似物停药中的作用：是友还是敌？
Hepatology. 2019 Apr;69(4):1843. doi: 10.1002/hep.30532. Epub 2019 Mar 18.
引用本文的文献
1
Response to: Comment on "48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse".对《慢性乙型肝炎患者核苷（酸）类似物治疗停药后48周结局及复发相关因素》评论的回应
Can J Gastroenterol Hepatol. 2019 May 2;2019:2970510. doi: 10.1155/2019/2970510. eCollection 2019.
本文引用的文献
1
Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy.血清乙型肝炎核心蛋白抗体水平与核苷（酸）类似物治疗停药后临床复发相关。
Clin Gastroenterol Hepatol. 2019 Jan;17(1):182-191.e1. doi: 10.1016/j.cgh.2018.05.047. Epub 2018 Jun 11.
2
48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse.核苷（酸）类似物治疗慢性乙型肝炎停药 48 周后的结局及复发的相关因素。
Can J Gastroenterol Hepatol. 2018 May 10;2018:1817680. doi: 10.1155/2018/1817680. eCollection 2018.
3
Is it possible to stop nucleos(t)ide analogue treatment in chronic hepatitis B patients?慢性乙型肝炎患者能否停止核苷（酸）类似物治疗？
World J Gastroenterol. 2018 May 7;24(17):1825-1838. doi: 10.3748/wjg.v24.i17.1825.
4
Diagnostic accuracy of liver stiffness measurement in chronic hepatitis B patients with normal or mildly elevated alanine transaminase levels.慢性乙型肝炎患者丙氨酸氨基转移酶水平正常或轻度升高时肝硬度测量的诊断准确性。
Sci Rep. 2018 Mar 27;8(1):5224. doi: 10.1038/s41598-018-23646-2.
5
Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study.乙肝病毒感染免疫耐受期儿童的抗病毒治疗：一项开放性、随机、对照研究
J Hepatol. 2018 Jun;68(6):1123-1128. doi: 10.1016/j.jhep.2018.01.037. Epub 2018 Feb 13.
6
Higher efficacy of pegylated interferon-α2b add-on therapy in hepatitis B envelope antigen-positive chronic hepatitis B patients on tenofovir monotherapy.聚乙二醇化干扰素-α2b 联合治疗对接受替诺福韦单药治疗的乙肝 e 抗原阳性慢性乙型肝炎患者疗效更佳。
Hepatol Res. 2018 May;48(6):451-458. doi: 10.1111/hepr.13049. Epub 2018 Mar 12.
7
Serum hepatitis B surface antigen levels predict insignificant fibrosis and non-cirrhosis in hepatitis B e antigen positive patients with normal or mildly elevated alanine transaminase levels.血清乙肝表面抗原水平可预测乙肝e抗原阳性、丙氨酸转氨酶水平正常或轻度升高患者的轻微肝纤维化和非肝硬化情况。
Oncotarget. 2017 Sep 23;8(49):86463-86470. doi: 10.18632/oncotarget.21210. eCollection 2017 Oct 17.
8
Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.在丙型肝炎病毒感染持续正常丙氨酸氨基转移酶患者中，FIB-4、天门冬氨酸氨基转移酶与血小板比值指数和肝硬度测量的诊断价值。
World J Gastroenterol. 2017 Aug 21;23(31):5746-5754. doi: 10.3748/wjg.v23.i31.5746.
9
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.EASL 2017 临床实践指南：乙型肝炎病毒感染管理。
J Hepatol. 2017 Aug;67(2):370-398. doi: 10.1016/j.jhep.2017.03.021. Epub 2017 Apr 18.
10
Health-related quality of life in patients with chronic hepatitis B during antiviral treatment and off-treatment.慢性乙型肝炎患者抗病毒治疗期间及停药后的健康相关生活质量
Patient Prefer Adherence. 2017 Jan 12;11:85-93. doi: 10.2147/PPA.S127139. eCollection 2017.
Zotero 插件